Nanomedicine kills tumors by knocking out single genes
At the Pennsylvania State College of Medicine, researchers have discovered that nanoparticles combined with two therapeutic molecules, when applied on human skin (a laboratory model) can ease and prevent it’s „dying“ of melanoma, the deadly skin cancer.
The nanoparticles are combined with siRNA molecules and they’re targeting two genes who are responsible for causing melanoma. They can destroy the damaged tissue and leave the healthy tissue intact.
„This method is very selective and targeted.“ says G. Robertson, PhD, who is the head of the researching crew at PSCM. „What really makes this method so special is that we can actually knock out single genes.“
The scientists suspect that siRNA turns off the two genes responsible for causing melanoma, and that way the disease can be treated more effectively.
Of course, delivering the siRNA to the cancer tissue is a complicated process. The skin has protective layers, but even if the drug passes them, the drug gets „destroyed“ by chemicals in the skin. To surpass this, PSCM scientists have developed nanoparticles based on lipids. That way they can pass through the skin without being degraded.
